Global Mifepristone Market Growth 2020-2025
According to this study, over the next five years the Mifepristone market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mifepristone business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Mifepristone market by type, application, key manufacturers and key regions and countries.
This study considers the Mifepristone value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablets
(Soft) Capsule
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
Pregnant,
Urged By The Check
Intrauterine Induction Of Labor After Fetal Death
Gynecologic Surgery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck Serono
Guangzhou Longsheng Pharmaceutical
Pfizer
Linepharma International
Monsanto/Searle
GenBioPro
Shanghai Xinhualian Pharmaceutical
Zhejiang Xianju Pharmaceutical
Huarun Zizhu Pharmaceutical
Hubei Gedian Renfu Pharmaceutical
Shenzhen Zifu Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Mifepristone consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Mifepristone market by identifying its various subsegments.
Focuses on the key global Mifepristone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mifepristone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Mifepristone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mifepristone Consumption 2015-2025
2.1.2 Mifepristone Consumption CAGR by Region
2.2 Mifepristone Segment by Type
2.2.1 Tablets
2.2.2 (Soft) Capsule
2.2.3 Other
2.3 Mifepristone Consumption by Type
2.3.1 Global Mifepristone Consumption Market Share by Type (2015-2020)
2.3.2 Global Mifepristone Revenue and Market Share by Type (2015-2020)
2.3.3 Global Mifepristone Sale Price by Type (2015-2020)
2.4 Mifepristone Segment by Application
2.4.1 Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
2.4.2 Pregnant,
2.4.3 Urged By The Check
2.4.4 Intrauterine Induction Of Labor After Fetal Death
2.4.5 Gynecologic Surgery
2.4.6 Other
2.5 Mifepristone Consumption by Application
2.5.1 Global Mifepristone Consumption Market Share by Type (2015-2020)
2.5.2 Global Mifepristone Value and Market Share by Type (2015-2020)
2.5.3 Global Mifepristone Sale Price by Type (2015-2020)
3 Global Mifepristone by Company
3.1 Global Mifepristone Sales Market Share by Company
3.1.1 Global Mifepristone Sales by Company (2018-2020)
3.1.2 Global Mifepristone Sales Market Share by Company (2018-2020)
3.2 Global Mifepristone Revenue Market Share by Company
3.2.1 Global Mifepristone Revenue by Company (2018-2020)
3.2.2 Global Mifepristone Revenue Market Share by Company (2018-2020)
3.3 Global Mifepristone Sale Price by Company
3.4 Global Mifepristone Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Mifepristone Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Mifepristone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Mifepristone by Regions
4.1 Mifepristone by Regions
4.2 Americas Mifepristone Consumption Growth
4.3 APAC Mifepristone Consumption Growth
4.4 Europe Mifepristone Consumption Growth
4.5 Middle East & Africa Mifepristone Consumption Growth
5 Americas
5.1 Americas Mifepristone Consumption by Countries
5.1.1 Americas Mifepristone Consumption by Countries (2015-2020)
5.1.2 Americas Mifepristone Value by Countries (2015-2020)
5.2 Americas Mifepristone Consumption by Type
5.3 Americas Mifepristone Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Mifepristone Consumption by Regions
6.1.1 APAC Mifepristone Consumption by Regions (2015-2020)
6.1.2 APAC Mifepristone Value by Regions (2015-2020)
6.2 APAC Mifepristone Consumption by Type
6.3 APAC Mifepristone Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Mifepristone by Countries
7.1.1 Europe Mifepristone Consumption by Countries (2015-2020)
7.1.2 Europe Mifepristone Value by Countries (2015-2020)
7.2 Europe Mifepristone Consumption by Type
7.3 Europe Mifepristone Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Mifepristone by Countries
8.1.1 Middle East & Africa Mifepristone Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Mifepristone Value by Countries (2015-2020)
8.2 Middle East & Africa Mifepristone Consumption by Type
8.3 Middle East & Africa Mifepristone Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mifepristone Distributors
10.3 Mifepristone Customer
11 Global Mifepristone Market Forecast
11.1 Global Mifepristone Consumption Forecast (2021-2025)
11.2 Global Mifepristone Forecast by Regions
11.2.1 Global Mifepristone Forecast by Regions (2021-2025)
11.2.2 Global Mifepristone Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Mifepristone Forecast by Type
11.8 Global Mifepristone Forecast by Application
12 Key Players Analysis
12.1 Merck Serono
12.1.1 Company Information
12.1.2 Mifepristone Product Offered
12.1.3 Merck Serono Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck Serono Latest Developments
12.2 Guangzhou Longsheng Pharmaceutical
12.2.1 Company Information
12.2.2 Mifepristone Product Offered
12.2.3 Guangzhou Longsheng Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Guangzhou Longsheng Pharmaceutical Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Mifepristone Product Offered
12.3.3 Pfizer Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Linepharma International
12.4.1 Company Information
12.4.2 Mifepristone Product Offered
12.4.3 Linepharma International Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Linepharma International Latest Developments
12.5 Monsanto/Searle
12.5.1 Company Information
12.5.2 Mifepristone Product Offered
12.5.3 Monsanto/Searle Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Monsanto/Searle Latest Developments
12.6 GenBioPro
12.6.1 Company Information
12.6.2 Mifepristone Product Offered
12.6.3 GenBioPro Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GenBioPro Latest Developments
12.7 Shanghai Xinhualian Pharmaceutical
12.7.1 Company Information
12.7.2 Mifepristone Product Offered
12.7.3 Shanghai Xinhualian Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Shanghai Xinhualian Pharmaceutical Latest Developments
12.8 Zhejiang Xianju Pharmaceutical
12.8.1 Company Information
12.8.2 Mifepristone Product Offered
12.8.3 Zhejiang Xianju Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Zhejiang Xianju Pharmaceutical Latest Developments
12.9 Huarun Zizhu Pharmaceutical
12.9.1 Company Information
12.9.2 Mifepristone Product Offered
12.9.3 Huarun Zizhu Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Huarun Zizhu Pharmaceutical Latest Developments
12.10 Hubei Gedian Renfu Pharmaceutical
12.10.1 Company Information
12.10.2 Mifepristone Product Offered
12.10.3 Hubei Gedian Renfu Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hubei Gedian Renfu Pharmaceutical Latest Developments
12.11 Shenzhen Zifu Pharmaceutical
12.11.1 Company Information
12.11.2 Mifepristone Product Offered
12.11.3 Shenzhen Zifu Pharmaceutical Mifepristone Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shenzhen Zifu Pharmaceutical Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Mifepristone Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablets
Table 5. Major Players of (Soft) Capsule
Table 6. Major Players of Other
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Mifepristone Consumption Market Share by Type (2015-2020)
Table 9. Global Mifepristone Revenue by Type (2015-2020) ($ million)
Table 10. Global Mifepristone Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Mifepristone Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Mifepristone Consumption Market Share by Application (2015-2020)
Table 14. Global Mifepristone Value by Application (2015-2020)
Table 15. Global Mifepristone Value Market Share by Application (2015-2020)
Table 16. Global Mifepristone Sale Price by Application (2015-2020)
Table 17. Global Mifepristone Sales by Company (2017-2019) (KG)
Table 18. Global Mifepristone Sales Market Share by Company (2017-2019)
Table 19. Global Mifepristone Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Mifepristone Revenue Market Share by Company (2017-2019)
Table 21. Global Mifepristone Sale Price by Company (2017-2019)
Table 22. Global Mifepristone Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Mifepristone Products Offered
Table 24. Mifepristone Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Mifepristone Consumption by Regions 2015-2020 (KG)
Table 26. Global Mifepristone Consumption Market Share by Regions 2015-2020
Table 27. Global Mifepristone Value by Regions 2015-2020 ($ Millions)
Table 28. Global Mifepristone Value Market Share by Regions 2015-2020
Table 29. Americas Mifepristone Consumption by Countries (2015-2020) (KG)
Table 30. Americas Mifepristone Consumption Market Share by Countries (2015-2020)
Table 31. Americas Mifepristone Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Mifepristone Value Market Share by Countries (2015-2020)
Table 33. Americas Mifepristone Consumption by Type (2015-2020) (KG)
Table 34. Americas Mifepristone Consumption Market Share by Type (2015-2020)
Table 35. Americas Mifepristone Consumption by Application (2015-2020) (KG)
Table 36. Americas Mifepristone Consumption Market Share by Application (2015-2020)
Table 37. APAC Mifepristone Consumption by Countries (2015-2020) (KG)
Table 38. APAC Mifepristone Consumption Market Share by Countries (2015-2020)
Table 39. APAC Mifepristone Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Mifepristone Value Market Share by Regions (2015-2020)
Table 41. APAC Mifepristone Consumption by Type (2015-2020) (KG)
Table 42. APAC Mifepristone Consumption Market Share by Type (2015-2020)
Table 43. APAC Mifepristone Consumption by Application (2015-2020) (KG)
Table 44. APAC Mifepristone Consumption Market Share by Application (2015-2020)
Table 45. Europe Mifepristone Consumption by Countries (2015-2020) (KG)
Table 46. Europe Mifepristone Consumption Market Share by Countries (2015-2020)
Table 47. Europe Mifepristone Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Mifepristone Value Market Share by Countries (2015-2020)
Table 49. Europe Mifepristone Consumption by Type (2015-2020) (KG)
Table 50. Europe Mifepristone Consumption Market Share by Type (2015-2020)
Table 51. Europe Mifepristone Consumption by Application (2015-2020) (KG)
Table 52. Europe Mifepristone Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Mifepristone Consumption by Countries (2015-2020) (KG)
Table 54. Middle East & Africa Mifepristone Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Mifepristone Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Mifepristone Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Mifepristone Consumption by Type (2015-2020) (KG)
Table 58. Middle East & Africa Mifepristone Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Mifepristone Consumption by Application (2015-2020) (KG)
Table 60. Middle East & Africa Mifepristone Consumption Market Share by Application (2015-2020)
Table 61. Mifepristone Distributors List
Table 62. Mifepristone Customer List
Table 63. Global Mifepristone Consumption Forecast by Countries (2021-2025) (KG)
Table 64. Global Mifepristone Consumption Market Forecast by Regions
Table 65. Global Mifepristone Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Mifepristone Value Market Share Forecast by Regions
Table 67. Global Mifepristone Consumption Forecast by Type (2021-2025) (KG)
Table 68. Global Mifepristone Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Mifepristone Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Mifepristone Value Market Share Forecast by Type (2021-2025)
Table 71. Global Mifepristone Consumption Forecast by Application (2021-2025) (KG)
Table 72. Global Mifepristone Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Mifepristone Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Mifepristone Value Market Share Forecast by Application (2021-2025)
Table 75. Merck Serono Product Offered
Table 76. Merck Serono Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 77. Merck Serono Main Business
Table 78. Merck Serono Latest Developments
Table 79. Merck Serono Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 80. Guangzhou Longsheng Pharmaceutical Product Offered
Table 81. Guangzhou Longsheng Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 82. Guangzhou Longsheng Pharmaceutical Main Business
Table 83. Guangzhou Longsheng Pharmaceutical Latest Developments
Table 84. Guangzhou Longsheng Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Product Offered
Table 86. Pfizer Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Pfizer Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 90. Linepharma International Product Offered
Table 91. Linepharma International Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 92. Linepharma International Main Business
Table 93. Linepharma International Latest Developments
Table 94. Linepharma International Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 95. Monsanto/Searle Product Offered
Table 96. Monsanto/Searle Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 97. Monsanto/Searle Main Business
Table 98. Monsanto/Searle Latest Developments
Table 99. Monsanto/Searle Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 100. GenBioPro Product Offered
Table 101. GenBioPro Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 102. GenBioPro Main Business
Table 103. GenBioPro Latest Developments
Table 104. GenBioPro Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 105. Shanghai Xinhualian Pharmaceutical Product Offered
Table 106. Shanghai Xinhualian Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 107. Shanghai Xinhualian Pharmaceutical Main Business
Table 108. Shanghai Xinhualian Pharmaceutical Latest Developments
Table 109. Shanghai Xinhualian Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 110. Zhejiang Xianju Pharmaceutical Product Offered
Table 111. Zhejiang Xianju Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 112. Zhejiang Xianju Pharmaceutical Main Business
Table 113. Zhejiang Xianju Pharmaceutical Latest Developments
Table 114. Zhejiang Xianju Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 115. Huarun Zizhu Pharmaceutical Product Offered
Table 116. Huarun Zizhu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 117. Huarun Zizhu Pharmaceutical Main Business
Table 118. Huarun Zizhu Pharmaceutical Latest Developments
Table 119. Huarun Zizhu Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 120. Hubei Gedian Renfu Pharmaceutical Product Offered
Table 121. Hubei Gedian Renfu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 122. Hubei Gedian Renfu Pharmaceutical Main Business
Table 123. Hubei Gedian Renfu Pharmaceutical Latest Developments
Table 124. Hubei Gedian Renfu Pharmaceutical Basic Information, Company Total Revenue (in $ million), Mifepristone Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen Zifu Pharmaceutical Product Offered
Table 126. Shenzhen Zifu Pharmaceutical Mifepristone Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 127. Shenzhen Zifu Pharmaceutical Main Business
Table 128. Shenzhen Zifu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Shenzhen Zifu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Mifepristone
Figure 2. Mifepristone Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Mifepristone Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Mifepristone Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablets
Figure 7. Product Picture of (Soft) Capsule
Figure 8. Product Picture of Other
Figure 9. Global Mifepristone Consumption Market Share by Type (2015-2020)
Figure 10. Global Mifepristone Value Market Share by Type (2015-2020)
Figure 11. Mifepristone Consumed in Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
Figure 12. Global Mifepristone Market: Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients) (2015-2020) (KG)
Figure 13. Global Mifepristone Market: Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients) (2015-2020) ($ Millions)
Figure 14. Mifepristone Consumed in Pregnant,
Figure 15. Global Mifepristone Market: Pregnant, (2015-2020) (KG)
Figure 16. Global Mifepristone Market: Pregnant, (2015-2020) ($ Millions)
Figure 17. Mifepristone Consumed in Urged By The Check
Figure 18. Global Mifepristone Market: Urged By The Check (2015-2020) (KG)
Figure 19. Global Mifepristone Market: Urged By The Check (2015-2020) ($ Millions)
Figure 20. Mifepristone Consumed in Intrauterine Induction Of Labor After Fetal Death
Figure 21. Global Mifepristone Market: Intrauterine Induction Of Labor After Fetal Death (2015-2020) (KG)
Figure 22. Global Mifepristone Market: Intrauterine Induction Of Labor After Fetal Death (2015-2020) ($ Millions)
Figure 23. Mifepristone Consumed in Gynecologic Surgery
Figure 24. Global Mifepristone Market: Gynecologic Surgery (2015-2020) (KG)
Figure 25. Global Mifepristone Market: Gynecologic Surgery (2015-2020) ($ Millions)
Figure 26. Mifepristone Consumed in Other
Figure 27. Global Mifepristone Consumption Market Share by Application (2015-2020)
Figure 28. Global Mifepristone Value Market Share by Application (2015-2020)
Figure 29. Global Mifepristone Sales Market Share by Company in 2017
Figure 30. Global Mifepristone Sales Market Share by Company in 2019
Figure 31. Global Mifepristone Revenue Market Share by Company in 2017
Figure 32. Global Mifepristone Revenue Market Share by Company in 2019
Figure 33. Global Mifepristone Sale Price by Company in 2019
Figure 34. Global Mifepristone Consumption Market Share by Regions 2015-2020
Figure 35. Global Mifepristone Value Market Share by Regions 2015-2020
Figure 36. Americas Mifepristone Consumption 2015-2020 (KG)
Figure 37. Americas Mifepristone Value 2015-2020 ($ Millions)
Figure 38. APAC Mifepristone Consumption 2015-2020 (KG)
Figure 39. APAC Mifepristone Value 2015-2020 ($ Millions)
Figure 40. Europe Mifepristone Consumption 2015-2020 (KG)
Figure 41. Europe Mifepristone Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Mifepristone Consumption 2015-2020 (KG)
Figure 43. Middle East & Africa Mifepristone Value 2015-2020 ($ Millions)
Figure 44. Americas Mifepristone Consumption Market Share by Countries in 2019
Figure 45. Americas Mifepristone Value Market Share by Countries in 2019
Figure 46. Americas Mifepristone Consumption Market Share by Type in 2019
Figure 47. Americas Mifepristone Consumption Market Share by Application in 2019
Figure 48. United States Mifepristone Consumption Growth 2015-2020 (KG)
Figure 49. United States Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Mifepristone Consumption Growth 2015-2020 (KG)
Figure 51. Canada Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Mifepristone Consumption Growth 2015-2020 (KG)
Figure 53. Mexico Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Mifepristone Consumption Market Share by Countries in 2019
Figure 55. APAC Mifepristone Value Market Share by Regions in 2019
Figure 56. APAC Mifepristone Consumption Market Share by Type in 2019
Figure 57. APAC Mifepristone Consumption Market Share by Application in 2019
Figure 58. China Mifepristone Consumption Growth 2015-2020 (KG)
Figure 59. China Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Mifepristone Consumption Growth 2015-2020 (KG)
Figure 61. Japan Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Mifepristone Consumption Growth 2015-2020 (KG)
Figure 63. Korea Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Mifepristone Consumption Growth 2015-2020 (KG)
Figure 65. Southeast Asia Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 66. India Mifepristone Consumption Growth 2015-2020 (KG)
Figure 67. India Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Mifepristone Consumption Growth 2015-2020 (KG)
Figure 69. Australia Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Mifepristone Consumption Market Share by Countries in 2019
Figure 71. Europe Mifepristone Value Market Share by Countries in 2019
Figure 72. Europe Mifepristone Consumption Market Share by Type in 2019
Figure 73. Europe Mifepristone Consumption Market Share by Application in 2019
Figure 74. Germany Mifepristone Consumption Growth 2015-2020 (KG)
Figure 75. Germany Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 76. France Mifepristone Consumption Growth 2015-2020 (KG)
Figure 77. France Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 78. UK Mifepristone Consumption Growth 2015-2020 (KG)
Figure 79. UK Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Mifepristone Consumption Growth 2015-2020 (KG)
Figure 81. Italy Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Mifepristone Consumption Growth 2015-2020 (KG)
Figure 83. Russia Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Mifepristone Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Mifepristone Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Mifepristone Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Mifepristone Consumption Market Share by Application in 2019
Figure 88. Egypt Mifepristone Consumption Growth 2015-2020 (KG)
Figure 89. Egypt Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Mifepristone Consumption Growth 2015-2020 (KG)
Figure 91. South Africa Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Mifepristone Consumption Growth 2015-2020 (KG)
Figure 93. Israel Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Mifepristone Consumption Growth 2015-2020 (KG)
Figure 95. Turkey Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Mifepristone Consumption Growth 2015-2020 (KG)
Figure 97. GCC Countries Mifepristone Value Growth 2015-2020 ($ Millions)
Figure 98. Global Mifepristone Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 99. Global Mifepristone Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Mifepristone Consumption 2021-2025 (KG)
Figure 101. Americas Mifepristone Value 2021-2025 ($ Millions)
Figure 102. APAC Mifepristone Consumption 2021-2025 (KG)
Figure 103. APAC Mifepristone Value 2021-2025 ($ Millions)
Figure 104. Europe Mifepristone Consumption 2021-2025 (KG)
Figure 105. Europe Mifepristone Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Mifepristone Consumption 2021-2025 (KG)
Figure 107. Middle East & Africa Mifepristone Value 2021-2025 ($ Millions)
Figure 108. United States Mifepristone Consumption 2021-2025 (KG)
Figure 109. United States Mifepristone Value 2021-2025 ($ Millions)
Figure 110. Canada Mifepristone Consumption 2021-2025 (KG)
Figure 111. Canada Mifepristone Value 2021-2025 ($ Millions)
Figure 112. Mexico Mifepristone Consumption 2021-2025 (KG)
Figure 113. Mexico Mifepristone Value 2021-2025 ($ Millions)
Figure 114. Brazil Mifepristone Consumption 2021-2025 (KG)
Figure 115. Brazil Mifepristone Value 2021-2025 ($ Millions)
Figure 116. China Mifepristone Consumption 2021-2025 (KG)
Figure 117. China Mifepristone Value 2021-2025 ($ Millions)
Figure 118. Japan Mifepristone Consumption 2021-2025 (KG)
Figure 119. Japan Mifepristone Value 2021-2025 ($ Millions)
Figure 120. Korea Mifepristone Consumption 2021-2025 (KG)
Figure 121. Korea Mifepristone Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Mifepristone Consumption 2021-2025 (KG)
Figure 123. Southeast Asia Mifepristone Value 2021-2025 ($ Millions)
Figure 124. India Mifepristone Consumption 2021-2025 (KG)
Figure 125. India Mifepristone Value 2021-2025 ($ Millions)
Figure 126. Australia Mifepristone Consumption 2021-2025 (KG)
Figure 127. Australia Mifepristone Value 2021-2025 ($ Millions)
Figure 128. Germany Mifepristone Consumption 2021-2025 (KG)
Figure 129. Germany Mifepristone Value 2021-2025 ($ Millions)
Figure 130. France Mifepristone Consumption 2021-2025 (KG)
Figure 131. France Mifepristone Value 2021-2025 ($ Millions)
Figure 132. UK Mifepristone Consumption 2021-2025 (KG)
Figure 133. UK Mifepristone Value 2021-2025 ($ Millions)
Figure 134. Italy Mifepristone Consumption 2021-2025 (KG)
Figure 135. Italy Mifepristone Value 2021-2025 ($ Millions)
Figure 136. Russia Mifepristone Consumption 2021-2025 (KG)
Figure 137. Russia Mifepristone Value 2021-2025 ($ Millions)
Figure 138. Spain Mifepristone Consumption 2021-2025 (KG)
Figure 139. Spain Mifepristone Value 2021-2025 ($ Millions)
Figure 140. Egypt Mifepristone Consumption 2021-2025 (KG)
Figure 141. Egypt Mifepristone Value 2021-2025 ($ Millions)
Figure 142. South Africa Mifepristone Consumption 2021-2025 (KG)
Figure 143. South Africa Mifepristone Value 2021-2025 ($ Millions)
Figure 144. Israel Mifepristone Consumption 2021-2025 (KG)
Figure 145. Israel Mifepristone Value 2021-2025 ($ Millions)
Figure 146. Turkey Mifepristone Consumption 2021-2025 (KG)
Figure 147. Turkey Mifepristone Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Mifepristone Consumption 2021-2025 (KG)
Figure 149. GCC Countries Mifepristone Value 2021-2025 ($ Millions)
Figure 150. Merck Serono Mifepristone Market Share (2018-2020)
Figure 151. Guangzhou Longsheng Pharmaceutical Mifepristone Market Share (2018-2020)
Figure 152. Pfizer Mifepristone Market Share (2018-2020)
Figure 153. Linepharma International Mifepristone Market Share (2018-2020)
Figure 154. Monsanto/Searle Mifepristone Market Share (2018-2020)
Figure 155. GenBioPro Mifepristone Market Share (2018-2020)
Figure 156. Shanghai Xinhualian Pharmaceutical Mifepristone Market Share (2018-2020)
Figure 157. Zhejiang Xianju Pharmaceutical Mifepristone Market Share (2018-2020)
Figure 158. Huarun Zizhu Pharmaceutical Mifepristone Market Share (2018-2020)
Figure 159. Hubei Gedian Renfu Pharmaceutical Mifepristone Market Share (2018-2020)
Figure 160. Shenzhen Zifu Pharmaceutical Mifepristone Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets